参考文献/References:
[1] Ruhlmann J, Schomburg A, Bender H, et al. Fluorode oxyglucose whole-body positron emission tomography in colorectal cancer patients studied in rourine daily practice[J].Dis Colon Rectum, 1997, 40:1195-1204.
[2] Hung GU, Shiau YC, Tsai SC, et al. Value of 18F-FDGPET in the evaluation of recurrent colorectal cancer[J]. Anticancer Res, 2001, 21(2B):1375-1378.
[3] Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer[J]. Ann Surg, 1998,27:319-323.
[4] Zhuang H, Sinha P, Pourdehnad M, et al. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver[J].Nucl Med Commun, 2000, 21(9):793-798.
[5] Fong Y, Choheb AM, Fortner JG, et al. Liver resection for colorectal metastases[J]. J Clin Oncol, 2001, 15:938-946.
[6] Jarnagin WR, Fong Y, Ky A, et al. Liver resection for metastatic colorectal cancer:. Assessing the risk of occult irresectabale disease[J]. J Am Coll Surg, 1999, 188:33-42.
[7] Fong Y, Saldinger PF, Akhurst T, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases[J]. Am J Surg, 1999, 178:282-287.
[8] Strasberg SM, Dehdashti F, Siegel BA, et al. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma:A prospective databases study[J]. Ann Surg, 2001, 233:293-299.
[9] Brennan MF. PET scanning in malignancy:Infant, adolescent or mature citizen[J]. Ann Surg, 2001, 233:320-321.
[10] Park KC, Schwimmer J, Shepherd JE, et al. Decision analysis for the cost-effective management of recurrent colorectal cancer[J]. Ann Surg, 2001, 233:310-319.
[11] Meta J, Seltzer M, Schiepers C, et al. Impact of 18F-FDG PET on managing patients with colorectal cancer:The referring physician’s perspective[J]. J Nucl Med, 2001, 42:586-590.
[12] Darius C, Desai MD, Emanuel E, et al. Positron emission tomography affects surgical management in recurrent colorectal cancer patients[J]. Ann Surg, 2003, 10:59-64.
[13] Whiteford MH, Whitefor HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocareinoma of the colon and rectum[J].Dis Colon Rectum, 2000, 43:759-770.
[14] Guillem JG, Puig-La CJ Jr, Akhursf T, et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18F-fluorodeoxyglucose positron emission tomography[J]. Dis Colon Rectum,2000, 43:18-24.
[15] Bender H, Bangard N, Metten N, et al. Possible role of FDG PET the early predication of therapy outcome in liver metastases of colorectal cancer[J]. Hybridoma, 1999, 18(1):87-91.
相似文献/References:
[1]左传涛.脑中风患者脑功能重塑研究中应注意的问题[J].国际放射医学核医学杂志,2005,29(1):1.
ZUO Chuan-tao.The issues in the study of brain plasticity after stroke[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):1.
[2]蔡莉,李彦生.氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究[J].国际放射医学核医学杂志,2005,29(1):10.
CAI Li,LI Yan-sheng.Comparison of 18F-FDG and amino acid PET imaging in brain tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):10.
[3]陈虞梅.肿瘤标记物在结直肠癌中的临床应用和研究[J].国际放射医学核医学杂志,2005,29(3):101.
CHEN Yu-mei.Clinical application and research of tumor markers in colorectal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):101.
[4]董爱生,田建明.部分癫痫的神经影像学诊断[J].国际放射医学核医学杂志,2005,29(4):148.
DONG Ai-sheng,TIAN Jian-ming.Neuroimaging in the diagnosis of partial epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):148.
[5]季仲友.PET-CT中诊断性CT的必要性与临床应用[J].国际放射医学核医学杂志,2005,29(5):197.
JI Zhong-you.Necessity and clinical application of diagnostic CT in PET-CT scanner[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):197.
[6]陈香,赵军,管一晖.PET-CT常见伪影[J].国际放射医学核医学杂志,2005,29(5):201.
CHEN Xiang,ZHAO Jun,GUAN Yi-hui.Common artifacts on PET-CT images[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):201.
[7]吴湖炳.18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值[J].国际放射医学核医学杂志,2005,29(5):205.
WU Hu-bing.The clinical application value of 18F-FDG PET-CT on the head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):205.
[8]董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国际放射医学核医学杂志,2005,29(5):209.
DONG Meng-jie,LIN Xiang-tong,ZHAO Jun.The application of PET-CT in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):209.
[9]刘建军,黄钢.18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究[J].国际放射医学核医学杂志,2005,29(5):213.
LIU Jian-jun,HUANG Gang.Application study of 18F-FDG PET and PET-CT on malignant bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):213.
[10]华逢春,管一晖,赵军.18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用[J].国际放射医学核医学杂志,2005,29(5):216.
HUA Feng-chun,GUAN Yi-hui,ZHAO Jun.18F-FDG PET and PET-CT imaging in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(1):216.